Events

Call for papers | The second infection Cooperation Forum and Oriental International Infectious Disease week

The 2nd infection Cooperation Forum and Oriental International Infectious Disease week call for papers.
September 15, 2023

The training course of standardized diagnosis and treatment of drug-resistant tuberculosis in Hebei Province and the launch ceremony of INSPIRE-TB project were successfully held in Baoding

Sponsored by National Medical Center for Infectious Diseases and Shanghai Huashen Institute of Microbes and Infections.
July 25, 2023

The latest research release: how safe and effective is rifapentine regimen in drug sensitive tuberculosis?

Tuberculosis is still a serious public health problem threatening human health worldwide. Therefore, the development of safe and strong bactericidal activity treatment strategy is the main way to shorten the treatment time, improve patient compliance and treatment success rate.
July 22, 2023

Notice on carrying out the "drug resistant tuberculosis adverse reaction management project"

Correct treatment of adverse events is of great significance to improve patient compliance and treatment success rate. The adverse reactions of drug-resistant tuberculosis treatment involve multiple systems, among which QT interval prolongation has the risk of causing fatal arrhythmia, which needs to be focused on in the management of clinical adverse events.
July 20, 2023

Focus on academic hot spots and argue for a new model of antiviral therapy and disease load detection

Hosted by Shanghai Huashen Institute of Microbes and Infections, entrusted by the National Medical Center for Infectious Diseases.
July 19, 2023

National Medical Center for Infectious Diseases and Shanghai Huashen Institute of Microbes and Infections work together with Janssen China to build an anti infection ecosystem

All parties will carry out strategic cooperation in scientific research, technological development, industrial transformation and academic exchanges, aiming to promote the sustainable development of the anti infection field, improve the level of public health, and help build a "healthy China 2030".
July 17, 2023